Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine
Main Authors: | Adel Gouri, Aoulia Dekaken, Khalid El Bairi, Arifa Aissaoui, Nihad Laabed, Mohamed Chefrour, Joseph Ciccolini, Gérard Milano, Sadek Benharkat |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-08-01
|
Series: | Biomarker Insights |
Online Access: | http://www.la-press.com/plasminogen-activator-system-and-breast-cancer-potential-role-in-thera-article-a5842 |
Similar Items
-
Plasminogen Activator System and Breast Cancer: Potential Role in Therapy Decision Making and Precision Medicine
by: Adel Gouri, et al.
Published: (2016-01-01) -
The association between adverse events and outcome under checkpoint inhibitors: Where is the deal?
by: Gerard Milano, et al.
Published: (2021-01-01) -
ALK inhibitors fuel ALK resistance mutation: Precision medicine takes on drug resistance
by: Gouri S Bhattacharyya, et al.
Published: (2020-01-01) -
Role of Her-2 in Gastrointestinal Tumours beyond Gastric Cancer: A Tool for Precision Medicine
by: Csongor G. Lengyel, et al.
Published: (2021-12-01) -
The effect of anti-human plasminogen monoclonal antibodies on Glu-plasminogen activation by plasminogen activators
by: M. Akrami, et al.
Published: (2006-07-01)